LBL.H — Lattice Biologics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Lattice Biologics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2016 September 30th | 2017 September 30th | 2018 September 30th | 2019 September 30th | 2020 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.93 | -1.52 | -1.23 | -1.01 | -1.48 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.41 | -1.72 | -0.213 | 0.302 | -0.035 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.55 | 2.27 | 1.51 | 0.667 | 1.67 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.61 | -0.747 | 0.264 | 0.162 | 0.536 |
| Capital Expenditures | -0.037 | -0.028 | -0.231 | -0.052 | -0.592 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.037 | -0.028 | -0.231 | -0.052 | -0.592 |
| Financing Cash Flow Items | 0.132 | — | — | — | 0.09 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.65 | 0.74 | -0.046 | -0.1 | 0.097 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.002 | -0.035 | -0.012 | 0.009 | 0.042 |